Influenza News and Research

Latest Influenza News and Research

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

22 Apr 2022
Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

22 Apr 2022
Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

21 Apr 2022
New approach successfully differentiates between antibodies against influenza and SARS-CoV-2

New approach successfully differentiates between antibodies against influenza and SARS-CoV-2

21 Apr 2022
Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

21 Apr 2022
Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

21 Apr 2022
Wearables can identify changes in physiological systems during COVID-19 disease progression

Wearables can identify changes in physiological systems during COVID-19 disease progression

19 Apr 2022
Researchers investigate COVID-19 data with logistic regression model training

Researchers investigate COVID-19 data with logistic regression model training

19 Apr 2022
Better ventilation can prevent covid spread. But are companies paying attention?

Better ventilation can prevent covid spread. But are companies paying attention?

19 Apr 2022
Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

18 Apr 2022
Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

18 Apr 2022
Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

18 Apr 2022
SARS-CoV-2 RBD is a selective integrin agonist

SARS-CoV-2 RBD is a selective integrin agonist

18 Apr 2022
Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

14 Apr 2022
The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

14 Apr 2022
Additional booster doses of COVID-19 vaccine help protect solid organ transplant recipients

Additional booster doses of COVID-19 vaccine help protect solid organ transplant recipients

13 Apr 2022
AI can help identify which symptoms are more likely to indicate COVID during flu season

AI can help identify which symptoms are more likely to indicate COVID during flu season

13 Apr 2022
Study determines hemagglutinin inhibition seroprevalence against swine influenza viruses circulating in Hong Kong and Guangzhou

Study determines hemagglutinin inhibition seroprevalence against swine influenza viruses circulating in Hong Kong and Guangzhou

13 Apr 2022
Study explores myopericarditis incidence and COVID-19 vaccination

Study explores myopericarditis incidence and COVID-19 vaccination

13 Apr 2022
The transmission dynamics of key SARS-CoV-2 mutations revealed by subtyping in new study

The transmission dynamics of key SARS-CoV-2 mutations revealed by subtyping in new study

13 Apr 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback